_Objectives_______________________
Upon completion of this symposium, participants should be better able to:
Thursday, February 23
Implement evidence-based best practice strategies that assist in the prevention of cardiovascular disease morbidity and mortality.
Name four conditions where exercise training helps manage or prevent cardiovascular disease.
Examine how psychological stress is defined and measured in terms of cardiovascular research.
Review the evidence for and against the concept that stress plays a role in cardiovascular disease.
Examine the different types of low-carbohydrate diets, and describe their effects on cardiometabolic risk
factors.
Explore the rationale for the use of a plant-based diet in diabetes management.
Explain the effect of diet interventions on blood glucose, lipids, and body weight.
Initiate and monitor therapeutic diets for patients with type 2 diabetes.
Explain the beneficial impact of the Mediterranean dietary pattern with improved health status and reductions in overall cardiovascular morbidity and mortality.
Examine the evolution of cardiovascular disease prevention, and explain how modern day aggressive treatment can lead to life-saving benefit.
Friday, February 24
Review the vascular biology of atherosclerosis and discuss the retention of ApoB lipoproteins with proteoglycans as the initiating factor in atherogenesis.
Explain the importance of LDL particle number as a predictor of CVD risk and as a target of therapy.
Identify and implement therapeutic strategies that can slow the progression and potentially lead to regression of atherosclerosis.
Discuss how triglycerides are related to “diabetic wannabes.”
Describe new and evolving therapies for the management of dyslipidemia.
Implement appropriate treatment strategies that can lower cardiometabolic risk and reduce cardiovascular events.
Implement patient management strategies that focus on raising HDL cholesterol rather than further lowering LDL cholesterol for patients at high risk for cardiovascular disease.
Explain the limitations of HDL cholesterol measurements currently used in clinical practice.
Utilize new system of HDL nomenclature based on physical and chemical characteristics.
Effectively interpret the clinical utility of advanced lipid testing and inflammatory markers in various cardiovascular disease states.
Consider new evidence regarding predictors of cardiovascular risk that challenged time-tested approaches and could impact patient evaluation and management.
Saturday, February 25
Describe the association between Vitamin D deficiency and cardiovascular risk and formulate an informed decision about who to screen and who to treat.
Aggressively treat hypertension to reduce adverse cardiovascular outcomes.
Define adiosopathy and sick fat as scientific and clinical terms, and formulate new approaches to patient discussions in an effort to improve compliance and healthy lifestyle management.
Educate women on the importance of seeking prompt emergency care for acute cardiovascular events in order to achieve optimal patient outcomes.
Discuss current cardiovascular disease prevention guidelines for women.
Implement evidenced-based clinical strategies for stroke prevention based on changes in the 2011 American Heart Association/American Stroke Association (AHA/ASA) guidelines.
Recognize the existence of residual cardiovascular risk in patients with normal LDL-C, and implement optimal approaches to evaluation and treatment of this group of patients.
Distinguish between metabolic syndrome traits/insulin resistance and LDL subclasses.
Examine the differential effects of commonly used lipid modifying agents on lipids and lipoproteins.
Sunday, February 26
Recognize three symptoms of myopathy and discuss a clinical approach to management.
Delineate the risks and benefits of aspirin for cardiovascular disease prevention in men and women.
Select the appropriate dose and timing, (age to treat) of aspirin therapy for primary and secondary prevention.
Decrease the elevated risk of adverse cardiovascular events associated with resistant hypertension.
Examine data and outcomes of the COURAGE Trial, and evaluate its impact on the treatment of stable coronary artery disease.
Critically analyze data and outcomes of the MARINE Trial, and evaluate its impact on management of lipids and inflammation.
Discuss the absolute benefit of carotid revascularization in patients with an asymptomatic stenosis.
Review how changes in medical therapy affect the risk-benefit ratio for carotid revascularization.
DISCLAIMER
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult FDA-approved uses and information prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying any information provided for any professional use.